Why Real-World Evidence Is Important for Real-World Cancer Patients

Posted by Jon Roffman on Jun 24, 2019 9:44:47 AM

“A lot of clinical trials are a bit artificial in that the eligibility criteria are ‘purple and pink polka dot patients,’ [but those patients] really don't exist.”

That was the start of my conversation with Dr. Julie Vose at the 2019 American Society of Clinical Oncology (ASCO) annual meeting, where we sat down to talk about real-world evidence and its importance in oncology. Dr. Vose is a believer in evidence-based medicine, and real-world evidence is an important tool in her arsenal for making treatment decisions at the University of Nebraska Medical Center, where she is the head of hematology and oncology.


>
Read More

Accelerating Real-World Evidence to Advance the Trial Landscape

Posted by Maria Whitman on Jul 19, 2017 9:42:04 AM

Mimi Traylor-Knowles co-wrote this blog post with Maria Whitman.

At the 2017 Annual Society of Clinical Oncology Annual Meeting (ASCO), Dr. Sean Khozin, senior medical officer at the FDA, opened his Saturday session with some trivia: When was the first controlled clinical trial? The answer, which surprised many of my fellow attendees, was 1747, when James Lind held a trial to determine if citrus juice would help control the symptoms of scurvy. Dr. Khozin then showed a timeline to demonstrate the history of controlled clinical trials. He concluded his session with a single but poignant visual: a flat line stretching more than 250 years from then until now. As the world has made historic progress in innovation—from steam locomotives to a man on the moon to the internet and all that we have today—controlled clinical trials have remained largely the same. 


>
Read More

Real-World Evidence Today and Tomorrow: The Role of Key Stakeholders

Posted by Maria Whitman on Jul 13, 2017 10:59:32 AM

Mimi Traylor-Knowles co-wrote this blog post with Maria Whitman.

Thomas Edison said: “There is a way to do it better. Find it.” Real-world evidence is a tool to help us do just that.

The theme at this year’s American Society of Clinical Oncology (ASCO) 2017 Annual Meeting (ASCO) was "Making a Difference in Cancer Care With YOU," which highlights the importance of everyone's involvement in improving care for patients with cancer. This theme also reminds us that improving care is part innovation and part application of what we have to do better.


>
Read More

Real-World Evidence as a Mechanism for Patient-Centric and Individualized Care

Posted by Maria Whitman on Jul 10, 2017 2:31:47 PM

Mimi Traylor-Knowles contributed to this blog post.

Recently, I sat in the audience of an oncology congress and heard a patient survivor and advocate describe critical transitions in his experience living with cancer: At diagnosis, he went from a “person” to a “patient,” and during clinical trial enrollment, he went from a “patient” to a “subject.” 


>
Read More